Myeloid deletion and therapeutic activation of AMP-activated protein kinase (AMPK) do not alter atherosclerosis in male or female mice
N. D. LeBlond, P. Ghorbani, C. O'Dwyer, N. Ambursley, J. R. Nunes, T. K. Smith, N. A. Trzaskalski, E. E. Mulvihill, V. Benoit, M. Foretz, M. D. Fullerton
This study shows that deleting AMPK in myeloid cells or activating it therapeutically does not affect atherosclerosis in male or female mice.
bioRxiv · Jul 15, 2020 · PreprintBiochemistry